Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Fred Kolling"'
Autor:
Chao Cheng, Keisuke Shirai, Jichang Han, Yanding Zhao, Tyler Searles, Nikhil Khatwani, Jennifer Vella, Fatima Haidar, Fred Kolling, Jiang Gui, Mary Turk, Christina Angeles
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/e4112b67fb7843cdaab7d42db03cb003
Autor:
Gary N. Schwartz, Peter A. Kaufman, Karthik V. Giridhar, Jonathan D. Marotti, Mary D. Chamberlin, Bradley A. Arrick, Grace Makari-Judson, Matthew P. Goetz, Shannon M. Soucy, Fred Kolling, Eugene Demidenko, Todd W. Miller
Publikováno v:
Clinical Cancer Research.
Purpose: Strategies to implement estrogen therapy for advanced estrogen receptor (ER)-positive breast cancer are under-developed. Preclinical data suggest that cycling treatment with 17b-estradiol followed by estrogen deprivation can control tumor gr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdb5a9447be560c88dc42827fd808db0
https://doi.org/10.1158/1078-0432.ccr-23-0112
https://doi.org/10.1158/1078-0432.ccr-23-0112
Autor:
Nicole A. Traphagen, Gary N. Schwartz, Steven Tau, Amanda Jiang, Sarah R. Hosford, Abigail E. Goen, Alyssa M. Roberts, Bianca A. Romo, Anneka L. Johnson, Emily-Claire K. Duffy, Eugene Demidenko, Paul Heverly, Yaron Mosesson, Shannon M. Soucy, Fred Kolling, Todd W. Miller
Publikováno v:
bioRxiv
PurposeClinical evidence indicates that treatment with estrogens elicits anti-cancer effects in ∼30% of patients with advanced endocrine-resistant estrogen receptor alpha (ER)-positive breast cancer. Despite the proven efficacy of estrogen therapy,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b6ad7bfdcd85b16f240bcc6b1b8624a
https://europepmc.org/articles/PMC10055145/
https://europepmc.org/articles/PMC10055145/
Autor:
Min Kyung Lee, Nasim Azizgolshani, Ze Zhang, Laurent Perreard, Fred Kolling IV, Lananh Nguyen, George Zanazzi, Lucas Salas, Brock Christensen
Although intratumoral heterogeneity has been established in pediatric central nervous system tumors, epigenomic alterations at the cell type level have largely remained unresolved. To identify cell type-specific alterations to cytosine modifications
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::330df0e5f6e491c04ac60d7ec42ae46d
https://doi.org/10.21203/rs.3.rs-2517758/v1
https://doi.org/10.21203/rs.3.rs-2517758/v1
Autor:
Min Kyung Lee, Nasim Azizgolshani, Joshua Shapiro, Lananh Nguyen, Fred Kolling IV, George Zanazzi, Hildredth Frost, Brock Christensen
Central nervous system (CNS) tumors are the leading cause of pediatric cancer death, and these patients have an increased risk for developing secondary neoplasms. Due to the low prevalence of pediatric CNS tumors, major advances in targeted therapies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::560067e65ff3e648acac9a656a69c341
https://doi.org/10.21203/rs.3.rs-2517703/v1
https://doi.org/10.21203/rs.3.rs-2517703/v1
Autor:
Fred Kolling, PhD
The Genomics and Molecular Biology Shared Resource (GMBSR) provides services for the isolation and analysis of DNA and RNA from bulk tissues and in single cells using microarray, Nanostring and next generation sequencing technologies. While the PI fu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9be2be3c87cece06de68ce8f26a46c8f
Autor:
Michael Fatemi, Eric Feng, Cyril Sharma, Zarif Azher, Tarushii Goel, Ojas Ramwala, Scott Palisoul, Rachael Barney, Laurent Perreard, Fred Kolling, Lucas A. Salas, Brock C. Christensen, Gregory Tsongalis, Louis Vaickus, Joshua J. Levy
Over 150,000 Americans are diagnosed with colorectal cancer (CRC) every year, and annually over 50,000 individuals will die from CRC, necessitating improvements in screening, prognostication, disease management, and therapeutic options. Tumor metasta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9dd6fe5ad782f96882f59d00a7cbdc43
https://doi.org/10.1101/2022.11.24.517856
https://doi.org/10.1101/2022.11.24.517856
Autor:
Ramya Reddy, Ram Reddy, Cyril Sharma, Christopher Jackson, Scott Palisoul, Rachael Barney, Fred Kolling, Lucas Salas, Brock Christensen, Gabriel Brooks, Gregory Tsongalis, Louis Vaickus, Joshua Levy
The characteristics of tumor-infiltrating lymphocytes (TIL) are essential in cancer prognostication and treatment through the ability to indicate the tumor’s capacity to evade the immune system (e.g., as evidenced by nodal involvement). Machine lea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c71efb6e141da3747822541bb636cda0
https://doi.org/10.1101/2022.08.28.505606
https://doi.org/10.1101/2022.08.28.505606
Autor:
Aleksey Molodtsov, Kathryn Lewis, Jichang Han, Jennifer Vella, Yanding Zhao, Brian Malik, Peisheng Zhang, Fred Kolling, Chao Cheng, Yina H Huang, Christina Angeles, Mary Jo Turk
Publikováno v:
The Journal of Immunology. 202:138.1-138.1
Tissue resident memory T cells (TRM cells) have recently been recognized as durable mediators of immunity to cancer. We previously showed that regulatory T cell-depleting immunotherapy of B16 melanoma induces protective TRM cells that persist in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f024037acadf2731bca90ae7ae0ad5a5
https://doi.org/10.4049/jimmunol.202.supp.138.1
https://doi.org/10.4049/jimmunol.202.supp.138.1